Steady State Plasma Levels of Bupropion After Administration of 3x150 Mg Extended Release Reference Tablets and Switching to 1x450 Mg Extended Release 450ER Tablets
Journal Title: International Journal of Clinical Pharmacology & Toxicology(IJCPT) - Year 2012, Vol 1, Issue 2
Abstract
In order to provide patients who take 450 mg/day bupropion hydrochloride for the treatment of severe depressive disorder with a safe and convenient alternative to currently existing dose regimens, a high-dose bupropion ER tablet formulation containing 450 mg of bupropion hydrochloride was developed. The results of the single dose pharmacokinetic study demonstrated bioequivalence of the 450 mg ER tablet with three tablets of the 150 mg strength taken at once, thus confirming that the 450 mg tablet is safe and effective. In addition, the simulation of steady state bupropion plasma levels after administration of 3x150 mg bupropion ER fasting and subsequent switch to 1x450 mg bupropion ER fed confirm that even under “worst case conditions” patients who switch from 3x150 mg to 1x450 mg bupropion ER won’t experience an elevated average Cmax and hence are not exposed to an increased risk of seizures.
Authors and Affiliations
Nadine Paiement
Effects of Ranitidine on Insulin and Lime - Induced Gastric Secretion in Albinowistar Rats
Purpose:To study the possible effect (s) of a relative H2-receptor blocker, ranitidine on lime and insulin-induced gastric secretion in male and female albino rats. Methods: The rats were divided into 3 groups of lime ju...
Strategies for the use of SPE
Strategies for the use of SPE
Efficacy of Montelukast and Ranitidine as an Add on Therapy for Chronic Urticaria
Background: Chronic urticaria is a highly distressing disease affecting a person’s quality of life. In most cases, monotherapy fails. Hence, combinations of antihistamines with montelukast, H2 blockers, ciclosporin, daps...
Current Pharmacological and Non-Pharmacological Treatments of Panic Disorder/Agoraphobia
Anxiety disorders represent the most prevalent psychiatric disorders, however, many patients who might benefit from treatment are not diagnosed or treated. This may partly be due to lack of awareness of the anxiety disor...
Evaluation of Health Related Quality of Life in Patient with Oral Cavity Squamous Cell Carcinoma Receiving Chemotherapy
Objective: To evaluate impact of chemotherapy on Health Related Quality of Life (HRQOL) in patients of oral cavity squamous cell carcinoma (OCSCC) by analysis of two different treatments named Concurrent Chemo - Radiatio...